Recce’s Phase 2 trial for skin infections hits midway recruitment milestone
Recce sees progression of Phase 2 study assessing efficacy of RECCE® 327 (R327G) topical gel against acute bacterial skin and...
Recce sees progression of Phase 2 study assessing efficacy of RECCE® 327 (R327G) topical gel against acute bacterial skin and...
Dr. Rian Kabir, a third-year psychiatry resident at the University of Louisville, always arrives to the school’s outpatient mental health...
Global Healthcare Private Equity Report Despite the slowdown in dealmaking in 2023, healthcare IT...